NEW BRUNSWICK, N.J., April 20, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the UBS Global Healthcare Conference on Tuesday, May 24th. Mathai Mammen, Executive Vice President, Pharmaceuticals R&D, will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time).
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
A webcast replay will be available approximately 48 hours after the live webcast.
SOURCE Johnson & Johnson
![](https://rt.prnewswire.com/rt.gif?NewsItemId=NY31040&Transmission_Id=202204201630PR_NEWS_USPR_____NY31040&DateId=20220420)
Share this article